Proteomics in Molecular Therapeutics

Proteomics is the expansive scale investigation of proteins. Proteins are key parts of living life forms, with numerous capacities. Proteomics permits portrayal of the proteins and peptide changes that make up the perplexing signalling systems that interconnect the cell movement. Proteomics has given us knowledge into the irritations of signalling pathways inside tumour cells and has encouraged the disclosure and portrayal of new medication targets.

 

    Related Conference of Proteomics in Molecular Therapeutics

    July 15-16, 2019

    4th International Conference on Molecular Medicine and Diagnostics

    Abu Dhabi, UAE | Radisson Blu Hotel, Abu Dhabi Yas Island
    July 29-30, 2019

    2nd Annual Biotechnology Congress

    | Chicago, Illinois, USA
    August 22-23, 2019

    5th International Congress on Epigenetics & Chromatin

    Vienna, Austria
    August 30-31, 2019

    International Conference on Genetic Disorders

    Bangkok, Thailand
    September 03-04, 2019

    International Conference On Genomics and Molecular Biology

    Prague | Czech Republic
    September 10-11, 2019

    International Conference on Cell and Gene Therapy

    | Prague, Czech Republic
    September 13-14, 2019

    12th World Congress on Cell & Tissue Science

    Singapore
    October 21-22, 2019

    23rd European Biotechnology Congress

    Zurich, Switzerland
    November 11-12, 2019

    2nd International Conference on Epigenetics and Human Diseases

    Amsterdam, Netherlands
    November 11-12, 2019

    6th World Congress on Epigenetics and Chromosome

    Amsterdam, Netherlands
    December 06-07, 2019

    4th World Biotechnology & Biofuels Congress

    Sao Paulo, Brazil
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    March 16-17, 2020 |

    12th World Congress and Expo on Cell & Stem Cell Research

    Chicago, Illinois, USA

    Proteomics in Molecular Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in